The study is currently not recruiting participants
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.
This trial is a research initiative exploring innovative treatments for diabetes. With participant's help, we test new methods, medications, or devices to potentially control, prevent, or even cure this prevalent condition. Your involvement accelerates our progress and societal wellbeing.
Respiratory Clinical Research refers to studies involving lung conditions and diseases like asthma, COPD, or pulmonary fibrosis. It seeks innovative treatments, preventive measures, and potentially cures via rigorous trial processes. Studies can range from drug trials to therapeutic methods.